drugset / Trial / NCT06482346
Clinical Pharmacology Study of MT-3534 in Healthy Adult Male Volunteers
RandomizedParallel-groupQuadruple-blindOther
Summary
This study is planned to investigate the safety, tolerability, and pharmacokinetics when a single intravenous dose of MT-3534 or a placebo is given to healthy adult male volunteers.
Timeline
- Start
- 2024-08-09
- Primary completion
- 2025-07-09
- Completion
- 2025-07-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MT-3534 | Unknown | — | Intravenous |
Indications
No indication recorded.